Home NDC 0054-0251 Irbesartan
Product NDC 0054-0251
11-digit product format 000540251
Labeler code 0054
Product ID 0054-0251_7d783004-ef17-4dcb-a3d9-4a965116ad4c
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Irbesartan
Dosage form TABLET
Route ORAL
Labeler West-Ward Pharmaceuticals Corp.
Application ANDA090201
Marketing category ANDA
Marketing start 2012-10-15
Marketing end 0000-00-00
Substance IRBESARTAN
Active strength 150 mg/1
Pharmacologic classes Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC]
NDC exclude flag No
Listing certified through 2020-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 36 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A090201-001 IRBESARTAN IRBESARTAN 75MG TABLET / ORAL 2012-10-15 A090201-002 IRBESARTAN IRBESARTAN 150MG TABLET / ORAL 2012-10-15 A090201-003 IRBESARTAN IRBESARTAN 300MG TABLET / ORAL 2012-10-15
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 123 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A090201-001 IRBESARTAN 75MG TABLET / ORAL 2012-10-15 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A090201-002 IRBESARTAN 150MG TABLET / ORAL 2012-10-15 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A090201-003 IRBESARTAN 300MG TABLET / ORAL 2012-10-15 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A090201-001 IRBESARTAN 75MG TABLET / ORAL 2012-10-15 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A090201-002 IRBESARTAN 150MG TABLET / ORAL 2012-10-15 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A090201-003 IRBESARTAN 300MG TABLET / ORAL 2012-10-15 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A090201-001 IRBESARTAN 75MG TABLET / ORAL 2012-10-15 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A090201-002 IRBESARTAN 150MG TABLET / ORAL 2012-10-15 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A090201-003 IRBESARTAN 300MG TABLET / ORAL 2012-10-15 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A090201-001 IRBESARTAN 75MG TABLET / ORAL 2012-10-15 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A090201-002 IRBESARTAN 150MG TABLET / ORAL 2012-10-15 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A090201-003 IRBESARTAN 300MG TABLET / ORAL 2012-10-15 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A090201-001 IRBESARTAN 75MG TABLET / ORAL 2012-10-15 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A090201-002 IRBESARTAN 150MG TABLET / ORAL 2012-10-15 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A090201-003 IRBESARTAN 300MG TABLET / ORAL 2012-10-15 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A090201-001 IRBESARTAN 75MG TABLET / ORAL 2012-10-15 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A090201-002 IRBESARTAN 150MG TABLET / ORAL 2012-10-15 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A090201-003 IRBESARTAN 300MG TABLET / ORAL 2012-10-15 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A090201-001 IRBESARTAN 75MG TABLET / ORAL 2012-10-15 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A090201-002 IRBESARTAN 150MG TABLET / ORAL 2012-10-15 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A090201-003 IRBESARTAN 300MG TABLET / ORAL 2012-10-15 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A090201-001 IRBESARTAN 75MG TABLET / ORAL 2012-10-15 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A090201-002 IRBESARTAN 150MG TABLET / ORAL 2012-10-15 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A090201-003 IRBESARTAN 300MG TABLET / ORAL 2012-10-15 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A090201-001 IRBESARTAN 75MG TABLET / ORAL 2012-10-15 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A090201-002 IRBESARTAN 150MG TABLET / ORAL 2012-10-15 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A090201-003 IRBESARTAN 300MG TABLET / ORAL 2012-10-15 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A090201-001 IRBESARTAN 75MG TABLET / ORAL 2012-10-15 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A090201-002 IRBESARTAN 150MG TABLET / ORAL 2012-10-15 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A090201-003 IRBESARTAN 300MG TABLET / ORAL 2012-10-15 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A090201-001 IRBESARTAN 75MG TABLET / ORAL 2012-10-15 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A090201-002 IRBESARTAN 150MG TABLET / ORAL 2012-10-15 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A090201-003 IRBESARTAN 300MG TABLET / ORAL 2012-10-15 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A090201-001 IRBESARTAN 75MG TABLET / ORAL 2012-10-15 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A090201-002 IRBESARTAN 150MG TABLET / ORAL 2012-10-15 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A090201-003 IRBESARTAN 300MG TABLET / ORAL 2012-10-15 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A090201-001 IRBESARTAN 75MG TABLET / ORAL 2012-10-15 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A090201-002 IRBESARTAN 150MG TABLET / ORAL 2012-10-15 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A090201-003 IRBESARTAN 300MG TABLET / ORAL 2012-10-15 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A090201-001 IRBESARTAN 75MG TABLET / ORAL 2012-10-15 8072bd15b7f6…
Observed Orange Book normalized TE history# DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded IRBESARTAN ACTIVE INGREDIENT J0E2756Z7N IRBESARTAN TABLET [ROXANE LABORATORIES, INC.] 2 IRBESARTAN ACTIVE MOIETY J0E2756Z7N IRBESARTAN TABLET [ROXANE LABORATORIES, INC.] 2 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U IRBESARTAN TABLET [ROXANE LABORATORIES, INC.] 2 CROSCARMELLOSE SODIUM INACTIVE INGREDIENT M28OL1HH48 IRBESARTAN TABLET [ROXANE LABORATORIES, INC.] 2 LACTOSE INACTIVE INGREDIENT J2B2A4N98G IRBESARTAN TABLET [ROXANE LABORATORIES, INC.] 2 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 IRBESARTAN TABLET [ROXANE LABORATORIES, INC.] 2 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 IRBESARTAN TABLET [ROXANE LABORATORIES, INC.] 2